239 Stock Overview
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Pak Fah Yeow International Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$2.49 |
52 Week High | HK$2.69 |
52 Week Low | HK$1.70 |
Beta | 0.23 |
1 Month Change | 0.40% |
3 Month Change | -0.80% |
1 Year Change | 39.89% |
3 Year Change | 81.75% |
5 Year Change | -2.73% |
Change since IPO | 433.57% |
Recent News & Updates
Why Pak Fah Yeow International's (HKG:239) Earnings Are Better Than They Seem
Sep 19Pak Fah Yeow International (HKG:239) Is Paying Out A Dividend Of HK$0.095
Aug 30Recent updates
Why Pak Fah Yeow International's (HKG:239) Earnings Are Better Than They Seem
Sep 19Pak Fah Yeow International (HKG:239) Is Paying Out A Dividend Of HK$0.095
Aug 30Here's Why We Think Pak Fah Yeow International (HKG:239) Might Deserve Your Attention Today
Nov 21Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Aug 31Calculating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
Jun 01Does Pak Fah Yeow International (HKG:239) Have A Healthy Balance Sheet?
Dec 12Pak Fah Yeow International's (HKG:239) Shareholders Will Receive A Smaller Dividend Than Last Year
Sep 02The Strong Earnings Posted By Pak Fah Yeow International (HKG:239) Are A Good Indication Of The Strength Of The Business
Sep 24Pak Fah Yeow International (HKG:239) Will Pay A Larger Dividend Than Last Year At HK$0.028
Aug 28Estimating The Intrinsic Value Of Pak Fah Yeow International Limited (HKG:239)
May 11Consider This Before Buying Pak Fah Yeow International Limited (HKG:239) For The 2.9% Dividend
Feb 21What Type Of Returns Would Pak Fah Yeow International's(HKG:239) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 17How Does Pak Fah Yeow International Limited (HKG:239) Fare As A Dividend Stock?
Nov 21Shareholder Returns
239 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -0.4% | 1.4% | 1.8% |
1Y | 39.9% | 4.7% | 24.2% |
Return vs Industry: 239 exceeded the Hong Kong Pharmaceuticals industry which returned 5.7% over the past year.
Return vs Market: 239 exceeded the Hong Kong Market which returned 24.4% over the past year.
Price Volatility
239 volatility | |
---|---|
239 Average Weekly Movement | 2.7% |
Pharmaceuticals Industry Average Movement | 4.9% |
Market Average Movement | 6.5% |
10% most volatile stocks in HK Market | 13.9% |
10% least volatile stocks in HK Market | 3.0% |
Stable Share Price: 239 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 239's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 101 | Wee Sean Gan | www.pakfahyeow.com |
Pak Fah Yeow International Limited, an investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name. It operates in three segments: Healthcare, Property Investments, and Treasury Investments. The company offers white flower embrocation medicated oils, strain relief products, and ointments, as well as Fúzai 239, a floral-scented white flower embrocation.
Pak Fah Yeow International Limited Fundamentals Summary
239 fundamental statistics | |
---|---|
Market cap | HK$775.98m |
Earnings (TTM) | HK$96.45m |
Revenue (TTM) | HK$265.79m |
8.0x
P/E Ratio2.9x
P/S RatioIs 239 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
239 income statement (TTM) | |
---|---|
Revenue | HK$265.79m |
Cost of Revenue | HK$34.77m |
Gross Profit | HK$231.02m |
Other Expenses | HK$134.57m |
Earnings | HK$96.45m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.31 |
Gross Margin | 86.92% |
Net Profit Margin | 36.29% |
Debt/Equity Ratio | 0.5% |
How did 239 perform over the long term?
See historical performance and comparisonDividends
8.6%
Current Dividend Yield22%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 05:01 |
End of Day Share Price | 2025/01/28 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Pak Fah Yeow International Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|